Serum progesterone testing to predict ectopic pregnancy in symptomatic first-trimester patients

Area of Science:

• Reproductive Endocrinology
• Emergency Medicine
• Diagnostic Accuracy

Background:

• Ectopic pregnancy is a leading cause of early pregnancy mortality.
• Accurate and timely diagnosis is crucial for effective management.
• Serum progesterone levels are being investigated as a biomarker for early pregnancy complications.

Purpose of the Study:

• To prospectively evaluate the accuracy of serum progesterone levels in detecting ectopic pregnancy.
• To establish a reliable cutoff value for progesterone to identify patients at low risk for ectopic pregnancy.

Main Methods:

• A prospective study of 716 symptomatic first-trimester emergency department patients.
• Serum progesterone levels measured by radioimmunoassay, with results blinded to treating physicians.
• Diagnosis confirmed by criterion standard, with patients monitored throughout.

Main Results:

• A progesterone cutoff of less than 22 ng/mL demonstrated 100% sensitivity and 100% negative predictive value for ectopic pregnancy.
• This cutoff classified approximately 25% of patients as low risk (0% risk of ectopic pregnancy).
• Specificity was 27% and positive predictive value was 10%.

Conclusions:

• Serum progesterone levels, with a cutoff of 22 ng/mL, can effectively identify low-risk patients for ectopic pregnancy.
• This biomarker may help expedite care and reduce the need for extensive diagnostic evaluations.
• Further research is needed to determine the clinical utility of rapid progesterone testing in managing early pregnancy complications.